4//SEC Filing
HealthCare Ventures IX, L.P. 4
Accession 0001104659-18-048864
CIK 0001509745other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 7:22 PM ET
Size
9.4 KB
Accession
0001104659-18-048864
Insider Transaction Report
Form 4
HealthCare Ventures IX, L.P.
10% Owner
Transactions
- Other
Warrant (Right to Buy)
2018-07-30−1,057,769→ 0 totalExercise: $6.08From: 2017-11-14Exp: 2024-11-14→ Common Stock (1,057,769 underlying)
Footnotes (1)
- [F1]HealthCare Ventures IX, L.P. ("HCV IX") distributed these warrants to its limited partners on a pro rata basis, for no consideration. In the distribution, Eli Lilly and Company, a 5% or greater stockholder of the Company and limited partner of HCV IX, received a warrant to purchase 331,221 shares of common stock. No shares of outstanding common stock were distributed. HCV IX continues to hold 3,573,376 shares of common stock, which represents 24.3% of the outstanding common stock.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001490245
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 7:22 PM ET
- Size
- 9.4 KB